← Open Payments lookup

SANDRA PELAEZ-MUNSEY: Open Payments

NPI 1942747126 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,068 in 93 payments from 13 companies in 2025. Trend: 2023 $3,029 · 2024 $11,492 · 2025 $2,068

Food & beverage: $2,068
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.15$391
ABBVIE INC.20$272
Lundbeck LLC13$268
E.R. Squibb & Sons, L.L.C.5$236
Axsome Therapeutics, Inc.11$216
Almatica Pharma LLC7$149
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$131
Takeda Pharmaceuticals U.S.A., Inc.4$89
Vanda Pharmaceuticals Inc.3$76
Tris Pharma Inc3$69

Products named: REXULTI, VRAYLAR, COBENFY, Auvelity, LOREEV XR, ABILIFY MAINTENA, CAPLYTA, TRINTELLIX.

Industry payments across FL — which companies pay providers there.